- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
4 result(s) found for: Precancerous condition.
Displaying page 1 of 1.
EudraCT Number: 2004-004258-26 | Sponsor Protocol Number: 02_2004 | Start Date*: 2005-06-23 |
Sponsor Name:University Clinic of Dermatology Division of Special and Enviromental Dermatology | ||
Full Title: Photodynamic Therapy (PDT) vs Chemopeeling for the treatment of multiple actinic keratoses on the underarms | ||
Medical condition: Actinic Keratosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2012-002052-17 | Sponsor Protocol Number: PITVIN | Start Date*: 2012-09-21 | |||||||||||
Sponsor Name:Medizinische Universität Graz, Univ. Frauenklinik, Abteilung für Gynäkologie | |||||||||||||
Full Title: Primary Imiquimod Treatment versus Surgery for Vulvar Intraepithelial Neoplasia: A Prospective Randomized Controlled Trial | |||||||||||||
Medical condition: Vulvar intraepithelial neoplasia | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-004349-18 | Sponsor Protocol Number: M-14789-41 | Start Date*: 2022-07-14 | |||||||||||
Sponsor Name:Almirall, S.A. | |||||||||||||
Full Title: A Phase 4, Multi-centre, Randomized, Evaluatorblinded, Active-controlled Study to Determine the Incidence of Squamous Cell Carcinoma and Evaluate the Long-term Safety of Tirbanibulin 10 mg/g Ointme... | |||||||||||||
Medical condition: Actinic Keratosis on the Face or Scalp | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: ES (Trial now transitioned) FR (Trial now transitioned) DE (Trial now transitioned) PL (Trial now transitioned) IT (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2006-001528-38 | Sponsor Protocol Number: PROSKIN 01 | Start Date*: 2007-01-12 |
Sponsor Name:Charité Universitätsmedizin Berlin | ||
Full Title: Prevention of skin cancer in high risk patients after conversion a to Sirolimus-based immunosuppressive | ||
Medical condition: Medical condition: renal transplant-patients at high-risk for skin cancer Transplant recipients have a high risk to develop skin malignancies. This depends on the immunosuppressive drugs and is rel... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
